KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Boston Scientific (BSX) Research & Development (2016 - 2025)

Historic Research & Development for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to $569.0 million.

  • Boston Scientific's Research & Development rose 2396.51% to $569.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.1 billion, marking a year-over-year increase of 2705.88%. This contributed to the annual value of $2.1 billion for FY2025, which is 2705.88% up from last year.
  • Per Boston Scientific's latest filing, its Research & Development stood at $569.0 million for Q4 2025, which was up 2396.51% from $514.0 million recorded in Q3 2025.
  • In the past 5 years, Boston Scientific's Research & Development ranged from a high of $569.0 million in Q4 2025 and a low of $276.0 million during Q1 2021
  • Over the past 5 years, Boston Scientific's median Research & Development value was $357.5 million (recorded in 2023), while the average stood at $380.4 million.
  • As far as peak fluctuations go, Boston Scientific's Research & Development crashed by 800.0% in 2021, and later soared by 3733.68% in 2025.
  • Quarter analysis of 5 years shows Boston Scientific's Research & Development stood at $320.0 million in 2021, then rose by 3.12% to $330.0 million in 2022, then increased by 10.0% to $363.0 million in 2023, then rose by 26.45% to $459.0 million in 2024, then grew by 23.97% to $569.0 million in 2025.
  • Its Research & Development was $569.0 million in Q4 2025, compared to $514.0 million in Q3 2025 and $526.0 million in Q2 2025.